GlassScriptPhysician profile
Ramakrishnan Ranganath
NPI 1225213028
$2,610.62
in general payments reported to CMS, 2019-2025
20 companies · $671 in 2025
The $671 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.36 · 2020: $220 · 2021: $583 · 2022: $286 · 2023: $376 · 2024: $458 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $741.63 | 2022-2025 | Symplicity G3, Hawkone, Abre |
| Novartis Pharmaceuticals Corporation | $297.88 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $229.53 | 2020-2024 | Farxiga |
| Stryker Corporation | $198.99 | 2025 | Artix Mt |
| Abiomed | $192.54 | 2021 | |
| Pfizer INC. | $187.69 | 2020-2023 | |
| Boston Scientific Corporation | $170.75 | 2023-2025 | Ranger, Eluvia |
| Shockwave Medical, INC | $116.96 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.31 | 2021 | |
| Merck Sharp & Dohme LLC | $80.11 | 2021-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $79.32 | 2022-2023 | Eliquis |
| Novo Nordisk INC | $79.03 | 2024-2025 | Wegovy, Ozempic |
| Janssen Pharmaceuticals, INC | $32.44 | 2019-2021 | |
| Penumbra, INC. | $25.94 | 2024 | Indigo System |
| Cvrx, INC. | $24.30 | 2025 | Barostim Neo System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.92 | 2021 | |
| Smith+Nephew, INC. | $14.65 | 2025 | Pico 7 |
| Tactile Systems Technology INC | $13.48 | 2023 | Entre Plus, Flexitouch Plus |
| Amgen INC. | $13.16 | 2023 | Repatha |
| Philips North America LLC | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramakrishnan Ranganath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.